#mironid Tech News.
1 story in the last 7 days
The latest mironid news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks mironid across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
HealthUKTNabout 1 hour ago
Mironid raises £34m for kidney disease drugGlasgow-based Mironid raised $46m (£34m) in Series B funding for its small molecule therapeutics targeting Autosomal Dominant Polycystic Kidney Disease (ADPKD). The company's LoAc molecules are the only drug class directly targeting cyclic AMP (cAMP), active in all stages of the disease. Preclinical data shows efficacy and a favourable safety profile.
Summaries by ByteBrief